28-03-2024
Profit beat expectations by the widest margin in at least five years, but the stock fell as the full-year outlook was lowered.
28-03-2024
Wedbush’s Dan Ives trims his stock-price target to $300 from $315 after a “perfect storm” of issues.
28-03-2024
“We are in our late 60s, in good health and we have a second home worth $900,000 that is fully paid for.”
28-03-2024
Investors can now make turbocharged bets on or against the Magnificent Seven group of stocks due to the launch of an exchange-traded product offering five times leverage on the hot megacap technology sector. Of course, that doesn’t mean they should.